PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1983 March; 76(3): 230–233.
PMCID: PMC1438716

Interferon therapy and immunity.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (683K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Arvin AM, Kushner JH, Feldman S, Baehner RL, Hammond D, Merigan TC. Human leukocyte interferon for the treatment of varicella in children with cancer. N Engl J Med. 1982 Apr 1;306(13):761–765. [PubMed]
  • Balkwill FR, Moodie EM, Freedman V, Fantes KH. Human interferon inhibits the growth of established human breast tumours in the nude mouse. Int J Cancer. 1982 Aug 15;30(2):231–235. [PubMed]
  • Balkwill F, Taylor-Papadimitriou J, Fantes KH, Sebesteny A. Human lymphoblastoid interferon can inhibit the growth of human breast cancer xenografts in athymic (nude) mice. Eur J Cancer. 1980 Apr;16(4):569–573. [PubMed]
  • Gresser I. On the varied biologic effects of interferon. Cell Immunol. 1977 Dec;34(2):406–415. [PubMed]
  • Gresser I, Morel-Maroger L, Rivière Y, Guillon JC, Tovey MG, Woodrow D, Sloper JC, Moss J. Interferon-induced disease in mice and rats. Ann N Y Acad Sci. 1980;350:12–20. [PubMed]
  • Gresser I, Tovey MG. Antitumor effects of interferon. Biochim Biophys Acta. 1978 Oct 27;516(2):231–247. [PubMed]
  • ISAACS A, BARON S. Antiviral action of interferon in embryonic cells. Lancet. 1960 Oct 29;2(7157):946–947. [PubMed]
  • JONES BR, GALBRAITH JE, AL-HUSSAINI MK. Vaccinial keratitis treated with interferon. Lancet. 1962 Apr 28;1(7235):875–879. [PubMed]
  • Merigan TC, Rand KH, Pollard RB, Abdallah PS, Jordan GW, Fried RP. Human leukocyte interferon for the treatment of herpes zoster in patients with cancer. N Engl J Med. 1978 May 4;298(18):981–987. [PubMed]
  • Merigan TC, Reed SE, Hall TS, Tyrrell DA. Inhibition of respiratory virus infection by locally applied interferon. Lancet. 1973 Mar 17;1(7803):563–567. [PubMed]
  • Scott GM, Phillpotts RJ, Wallace J, Secher DS, Cantell K, Tyrrell DA. Purified interferon as protection against rhinovirus infection. Br Med J (Clin Res Ed) 1982 Jun 19;284(6332):1822–1825. [PMC free article] [PubMed]
  • Scott GM, Secher DS, Flowers D, Bate J, Cantell K, Tyrrell DA. Toxicity of interferon. Br Med J (Clin Res Ed) 1981 Apr 25;282(6273):1345–1348. [PMC free article] [PubMed]
  • Scott GM, Tyrrell DA. Interferon: therapeutic fact or fiction for the '80s? Br Med J. 1980 Jun 28;280(6231):1558–1562. [PMC free article] [PubMed]
  • Sundmacher R, Cantell K, Skoda R, Hallermann C, Neumann-Haefelin D. Human leukocyte and fibroblast interferon in a combination therapy of dendritic keratitis. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1978 Nov 30;208(4):229–233. [PubMed]
  • Taylor-Papadimitriou J, Balkwill FR. Implications for clinical application of new developments in interferon research. Biochim Biophys Acta. 1982 Sep 30;695(1):49–67. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press